Isodicentric Chromosome 15 Syndrome (Year of the Zebra 2026)
Why It Matters
Understanding IDIC‑15 enables early diagnosis and targeted multidisciplinary care, reducing developmental disability and informing family planning.
Key Takeaways
- •IDIC 15 adds extra maternal 15q copies, increasing gene dosage
- •Three active maternal genes cause neurodevelopmental delays and autism traits
- •Seizures often emerge in childhood, requiring anti‑seizure medication
- •Diagnosis relies on karyotype, FISH, and parental origin testing
- •Early multidisciplinary therapy improves outcomes for motor, speech, and behavior
Summary
Isodicentric chromosome 15 (IDIC‑15) syndrome is a rare genetic disorder caused by an extra super‑numerary marker chromosome derived from the long arm of chromosome 15. The marker contains duplicated 15q material that is typically of maternal origin, resulting in three active copies of imprinted genes instead of the usual single maternal copy. This dosage imbalance underlies the clinical phenotype.
Patients commonly present with low muscle tone, delayed motor milestones, speech delays, learning difficulties, and autism‑spectrum behaviors. Seizures develop in many children, often refractory to standard therapy. Facial dysmorphisms such as a flattened nasal bridge, epicanthal folds, and low‑set ears are subtle but characteristic. Mosaicism can moderate severity, with milder symptoms when only a subset of cells carries the extra chromosome.
Diagnostic work‑up begins with a conventional karyotype to detect the marker chromosome, followed by fluorescence in situ hybridisation (FISH) or chromosomal microarray to map the duplicated region. Parental origin testing confirms maternal inheritance, guiding recurrence risk counseling. Management is multidisciplinary, emphasizing early physical, occupational and speech therapy, behavioral interventions for autism features, and anti‑seizure medications when needed.
The condition illustrates how genomic imprinting and copy‑number variation translate into neurodevelopmental disease, underscoring the importance of precise genetic testing and early therapeutic intervention. Clinicians equipped with this knowledge can better counsel families, anticipate complications, and coordinate care to improve long‑term outcomes.
Comments
Want to join the conversation?
Loading comments...